To investigate the diagnostic value of ultralow-dose computed tomography in the detection of pulmonary nodules and lung parenchym alterations (e.g. emphysema) compared to standard-dose-CT.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Enrollment
500
Patients undergoing thoracic normal dose-CT with undergo an additional Ultralow-Dose-CT
Klinik für Radiologie und Nuklearmedizin
Sankt Gallen, Switzerland
RECRUITINGNumber of pulmonary Nodules detected in the Ultralow-Dose thoracic CT
Difference in nodule detectability in Ultralow-Dose-CT compared to Standard-Dose-CT measured using McNemar test
Time frame: Participants CT-scan will be read out on an average date of 6 weeks after the scan
Patients BMI (Body mass index)
Time frame: Measures assessed at time of read-out on an average date of 6 weeks after the scan
Patients Nodule size (mm)
Time frame: Measures assessed at time of read-out on an average date of 6 weeks after the scan
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.